The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Exchanging ESAT6 with TB10.4 in an Ag85B Fusion Molecule-Based Tuberculosis Subunit Vaccine: Efficient Protection and ESAT6-Based Sensitive Monitoring of Vaccine Efficacy
Open accessAbstract
Previously we have shown that Ag85B-ESAT-6 is a highly efficient vaccine against tuberculosis. However, because the ESAT-6 Ag is also an extremely valuable diagnostic reagent, finding a vaccine as effective as Ag85B-ESAT-6 that does not contain ESAT-6 is a high priority. Recently, we identified a novel protein expressed by Mycobacterium tuberculosis designated TB10.4. In most infected humans, TB10.4 is strongly recognized, raising interest in TB10.4 as a potential vaccine candidate and substitute for ESAT-6. We have now examined the vaccine potential of this protein and found that vaccination with TB10.4 induced a significant protection against tuberculosis. Fusing Ag85B to TB10.4 produced an even more effective vaccine, which induced protection against tuberculosis comparable to bacillus Calmette-Guérin vaccination and superior to the individual Ag components. Thus, Ag85B-TB10 represents a new promising vaccine candidate against tuberculosis. Furthermore, having now exchanged ESAT-6 for TB10.4, we show that ESAT-6, apart from being an excellent diagnostic reagent, can also be used as a reagent for monitoring vaccine efficacy. This may open a new way for monitoring vaccine efficacy in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847 · cited 1×
“4), respectively (31), except that the 51-bp sequence encoding the NH2-terminal 17 aa residues of Ag85B have been changed without changing the identity of the translated product to destabilize the secondary structure of the RNA transcript for improved translation initiation in Escherichia coli (32).”
BackgroundEfficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature
Colditz, G. A. (1994) · JAMA · doi:10.1001/jama.1994.03510330076038 · Cited by 1,918
Variation in protection by BCG: implications of and for heterologous immunity
Fine, P. E. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92348-9 · Cited by 1,380
Colditz, G. A., Berkey, C. S., Mosteller, F., Brewer, T. F., Wilson, M. E., Burdick, E., & Fineberg, H. V. (1995) · Pediatrics · doi:10.1542/peds.96.1.29 · Cited by 763
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
Huygen, K., Content, J., Denis, O., Montgomery, D. L., Yawman, A. M., Randall Deck, R., DeWitt, C. M., Orme, I. M., Baldwin, S., D'Souza, C., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-893 · Cited by 629
McShane, H., Pathan, A. A., Sander, C. R., Keating, S. M., Gilbert, S. C., Huygen, K., Fletcher, H. A., & Hill, A. V. S. (2004) · Nature Medicine · doi:10.1038/nm1128 · Cited by 570
Vaccination against tuberculosis by DNA injection
Tascon, R. E., Colston, M. J., Ragno, S., Stavropoulos, E., Gregory, D., & Lowrie, D. B. (1996) · Nature Medicine · doi:10.1038/nm0896-888 · Cited by 506
Horwitz, M. A., Harth, G., Dillon, B. J., & Masleša-Galić, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250480397 · Cited by 436
Horwitz, M. A., Lee, B. W., Dillon, B. J., & Harth, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1530 · Cited by 432
Rapid Detection of Mycobacterium tuberculosis Infection by Enumeration of Antigen-specific T Cells
LALVANI, A., PATHAN, A. A., McSHANE, H., WILKINSON, R. J., LATIF, M., CONLON, C. P., PASVOL, G., & HILL, A. V. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.4.2009100 · Cited by 427
Cited by
A multistage tuberculosis vaccine that confers efficient protection before and after exposure
Aagaard, C., Hoang, T., Dietrich, J., Cardona, P.-J., Izzo, A., Dolganov, G., Schoolnik, G. K., Cassidy, J. P., Billeskov, R., & Andersen, P. (2011) · Nature Medicine · doi:10.1038/nm.2285 · Cited by 527
Self-citationNewton, S. M., Brent, A. J., Anderson, S., Whittaker, E., & Kampmann, B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70182-8 · Cited by 480
Bertholet, S., Ireton, G. C., Ordway, D. J., Windish, H. P., Pine, S. O., Kahn, M., Phan, T., Orme, I. M., Vedvick, T. S., Baldwin, S. L., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001094 · Cited by 305
Kaufmann, S. H., Hussey, G., & Lambert, P.-H. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60393-5 · Cited by 299
Advances in tuberculosis vaccine strategies
Skeiky, Y. A. W., & Sadoff, J. C. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1419 · Cited by 299
Agger, E. M., Rosenkrands, I., Hansen, J., Brahimi, K., Vandahl, B. S., Aagaard, C., Werninghaus, K., Kirschning, C., Lang, R., Christensen, D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003116 · Cited by 287
Self-citationRelease of mycobacterial antigens
Majlessi, L., Prados‐Rosales, R., Casadevall, A., & Brosch, R. (2015) · Immunological Reviews · doi:10.1111/imr.12251 · Cited by 93
Metadata
- Authors
- Dietrich, J., Aagaard, C., Leah, R., Olsen, A. W., Stryhn, A., Doherty, T. M., & Andersen, P.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05
- Volume
- 174
- Issue
- 10
- Pages
- 6332-6339
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1552600293
- Cited by
- 252
- References
- 31
- FWCI
- 10.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.